COMPANY SUMMARY Zydus Therapeutics (ZTI) is a clinical-stage, specialty-focused bio-pharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. Our lead drug candidate, saroglitazar, is a dual PPAR alpha / gamma agonist that has received FDA Fast Tra